Many die because melanoma is not detected early, with the Melbourne pathology company behind the test saying it could make a “massive difference”. The test will pave the way for earlier ...
The method uses patients' pathology reports to automate the classification of patients by the severity of their cancers, potentially shortening the process of selecting candidates for clinical trials.